These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Triple acupuncture at the Qugu acupoint as an adjunctive therapy for type-Ⅲ chronic prostatitis: Analysis of short- and long-term clinical effects].
    Author: Zhang XY, Luo SB, Zhang JY, Meng ZC.
    Journal: Zhonghua Nan Ke Xue; 2017 May; 23(5):464-467. PubMed ID: 29717841.
    Abstract:
    OBJECTIVE: To investigate the short- and long-term effects of triple acupuncture at the Qugu acupoint as an adjunctive therapy on type-Ⅲ chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS). METHODS: We equally randomized 90 CP/CPPS patients into a control and a treatment group, both treated with Levofloxacin Mesylate Tablets (0.5 g, tid) + Terazosin Hydrochloride Capsules (2 mg qd) for 4 weeks, while the latter group by triple acupuncture at the Qugu acupoint as an adjunctive therapy twice a week at the same time. Then, we followed up all the patients for 4 weeks, recorded the cases, time and rate of recurrence, obtained the scores in National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), quality of life (QoL) and Zung Depression Scale (ZDS), and compared them between the two groups of patients. RESULTS: Compared with the controls, the patients of the treatment group showed significantly decreased NIH-CPSI scores in pain (8.6 ± 2.12 vs 6.2 ± 2.25, P <0.05), micturition (5.8 ± 1.22 vs 3.1 ± 1.10, P <0.05), and QoL (6.0 ± 1.33 vs 3.4 ± 1.71, P <0.05) and ZDS score as well (43.9 ± 4.53 vs 33.6 ± 3.20, P <0.01). The recurrence rate was markedly lower while the recurrence time remarkably longer in the treatment than in the control group (15.56 vs 35.56% and ［20.0 ± 2.72］ vs ［12.5 ± 3.47］ d, P <0.05). CONCLUSIONS: As an adjunctive therapy, triple acupuncture at the Qugu acupoint can evidently ameliorate the clinical symptoms, enhance the curative effect of antibacterials, reduce the recurrence rate, and prolong the recurrence time in the treatment of CP/CPPS. 目的: 研究针刺曲骨穴辅助治疗Ⅲ型前列腺炎（CP/CPPS）的近远期疗效。方法: 将90例CP/CPPS患者按数字表法随机分为两组，对照组45例用甲磺酸左氧氟沙星片0.5 g 口服，1次/d + 盐酸特拉唑嗪片2 mg睡前服，治疗组45例在对照组治疗基础上加针刺曲骨穴进行治疗，疗程均为4周。疗程结束后，所有病例4周后均随访，记录复发人数及复发时间，计算并比较治疗后两组间NIH慢性前列腺炎症状评分表(CPSI)、生活质量(QoL) 评分、Zung抑郁量表评分以及复发率和复发时间。 结果: 治疗后，治疗组尿频、尿急、尿不尽、小腹会阴疼痛不适、抑郁情绪等症状明显缓解；与对照组比较,治疗组CPSI(8.6±2.12 vs 6.2±2.25, P<0.05)、QoL评分(6.0±1.33 vs 3.4±1.71, P<0.01)、Zung评分(43.9±4.53 vs 33.6±3.20, P<0.01)显著下降,差异明显。 结论: 针刺曲骨穴辅助治疗CP/CPPS,可明显改善患者的临床症状、提高抗菌药物的治疗效果，并有助于减少CP/CPPS的复发率、延长复发时间。.
    [Abstract] [Full Text] [Related] [New Search]